Cargando…
A novel binding pocket in the D2 domain of protein tyrosine phosphatase mu (PTPmu) guides AI screen to identify small molecules that modulate tumour cell adhesion, growth and migration
Approximately 40% of people will get cancer in their lifetime in the US, and 20% are predicted to die from the condition when it is invasive and metastatic. Targeted screening for drugs that interact with proteins that drive cancer cell growth and migration can lead to new therapies. We screened mol...
Autores principales: | Molyneaux, Kathleen, Laggner, Christian, Brady‐Kalnay, Susann M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660673/ https://www.ncbi.nlm.nih.gov/pubmed/37860940 http://dx.doi.org/10.1111/jcmm.17973 |
Ejemplares similares
-
Artificial Intelligence-Based Computational Screening and Functional Assays Identify Candidate Small Molecule Antagonists of PTPmu-Dependent Adhesion
por: Molyneaux, Kathleen, et al.
Publicado: (2023) -
Small molecule antagonists of PTPmu identified by artificial intelligence-based computational screening block glioma cell migration and growth
por: Molyneaux, Kathleen, et al.
Publicado: (2023) -
A PTPmu Biomarker is Associated with Increased Survival in Gliomas
por: Johansen, Mette L., et al.
Publicado: (2019) -
Detection of Tumor-Specific PTPmu in Gynecological Cancer and Patient Derived Xenografts
por: Vincent, Jason, et al.
Publicado: (2021) -
Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo
Publicado: (1995)